CAS, a division of the American Chemical Society, announced late last month a collaboration with Novartis Biomedical Research to help advance artificial intelligence–enabled research including reaction data accessibility.
CAS, which manages over 160 million scientist-curated reactions through the CAS Content Collection, will give researchers at Novartis access to proprietary experimental reaction data to use alongside the collection.
